Atlanta Braves Holdings, Inc. filings document formal disclosures for a public holding company whose operating assets include the Atlanta Braves Major League Baseball Club, Truist Park and The Battery Atlanta. Form 8-K reports furnish quarterly and annual operating results by Baseball and Mixed-Use Development, with discussion of revenue sources, operating costs, Adjusted OIBDA and Regulation FD announcements such as BravesVision.
Proxy materials disclose annual meeting matters, stockholder voting procedures and governance proposals. The filings also identify the company's common stock classes, Nasdaq listing information and incorporation jurisdiction for a business combining professional sports operations, stadium activities and mixed-use real estate.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 733,932 shares of Atlanta Braves Holdings Inc common stock, representing 7.11% of the class as of the event date of 12/31/2025.
Vanguard reports shared voting power over 144,675 shares and shared dispositive power over all 733,932 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
The filing also notes that on 01/12/2026 Vanguard underwent an internal realignment, after which certain subsidiaries or business divisions with beneficial ownership will report on a disaggregated basis. Vanguard’s clients, including registered investment companies and other managed accounts, have rights to dividends or sale proceeds, but no single other person has more than a 5% interest in these securities.
The Vanguard Group reported beneficial ownership of 2,789,081 shares of Atlanta Braves Holdings Inc. common stock, representing 5.4% of the class as of the event date 12/31/2025.
Vanguard reports shared voting power over 326,604 shares and shared dispositive power over all 2,789,081 shares, with no sole voting or dispositive power. The shares are held on behalf of Vanguard’s clients, none of whom individually owns more than 5% of the class. Vanguard notes an internal realignment effective 01/12/2026, after which certain subsidiaries are expected to report beneficial ownership separately.
Atlanta Braves Holdings, Inc.'s EVP, CLO & Secretary reported vesting of restricted stock units and a related share sale in Series C common stock.
On December 11, 2025, 7,660 restricted stock units converted into 7,660 shares of Series C common stock at $0, resulting in 30,164 shares directly owned. On December 12, 2025, the officer sold 7,423 shares at a weighted average price of $39.71, in part to cover tax withholding obligations, and afterward held 22,741 Series C shares and 7,661 restricted stock units.
Atlanta Braves Holdings, Inc. executive vice president of development reported equity award activity involving Series C Common Stock (BATRK). On December 11, 2025, 11,142 restricted stock units converted into an equal number of shares at $0, bringing direct holdings to 250,467 shares. On December 12, 2025, 4,874 shares were sold at a weighted average price of $39.74 to cover tax withholding tied to the vesting, leaving 245,593 shares held directly. The report also notes 55,503 shares held indirectly through a grantor retained annuity trust and 11,142 restricted stock units outstanding, with the remaining units scheduled to vest on December 11, 2026.
Atlanta Braves Holdings, Inc. reported that its EVP, CFO & Treasurer converted 7,660 restricted stock units into Series C Common Stock on December 11, 2025, at an exercise price of $0 per share. On December 12, 2025, the executive sold 3,830 Series C shares in an open-market transaction coded as a sale, at a weighted average price of $39.70.
The sale was carried out under a Rule 10b5-1 sales plan adopted on May 15, 2025 and was intended to cover tax withholding obligations tied to the RSU vesting. The price range for the sale was from $39.37 to $40.12. After these transactions, the executive directly held 79,460 Series C shares, and the remaining restricted stock units continue vesting in tranches, with the final portion scheduled to vest on December 11, 2026.
Atlanta Braves Holdings, Inc. reported insider activity by its EVP, Business. On December 11, 2025, restricted stock units converted into 11,142 shares of Series C Common Stock at an exercise price of $0, increasing the officer's direct holdings to 321,782 shares.
On December 12, 2025, the officer sold 4,874 shares at a weighted average price of $39.73, within a range of $39.37 to $40.12, to cover tax withholding obligations related to the RSU vesting. After these transactions, the officer directly owns 316,908 shares of Series C Common Stock and holds 11,142 restricted stock units, with the remaining units scheduled to vest on December 11, 2026.
A senior insider of Atlanta Braves Holdings, Inc. who serves as chairman, president and CEO and a 10% owner reported equity award activity in Series C common stock.
On December 11, 2025, 15,042 restricted stock units converted into the same number of Series C shares at $0. On December 12, 2025, 6,688 shares were sold at a weighted average price of $39.72 to cover tax withholding, leaving 248,695 Series C shares held directly.
An additional 265,000 Series C shares are held indirectly through a trust. The restricted stock units vest in three equal installments on December 11, 2024, 2025 and 2026.
Atlanta Braves Holdings, Inc. reported equity transactions by a company executive serving as EVP, Chief People & Culture Officer. On December 11, 2025, 1,880 restricted stock units converted into an equal number of Series C Common Stock shares at $0 per share. On December 12, 2025, 826 Series C shares were sold at a weighted average price of $39.71 to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
Following these transactions, the executive directly owned 6,040 Series C Common Stock shares and 1,881 remaining restricted stock units. The RSU award vests in three equal installments, with one-third having vested on December 11, 2024 and 2025, and the final third scheduled to vest on December 11, 2026.
Atlanta Braves Holdings, Inc. (BATRA) reported an insider stock purchase by a company director on 11/19/2025. The director bought 2,259 shares of Series A Common Stock at a price of $42 per share, increasing the director's directly held position to 486,862 shares. In addition, 10,177 shares are held indirectly through the Leslie A. Malone 1995 Revocable Trust, for which the reporting person disclaims beneficial ownership.
Atlanta Braves Holdings, Inc. (BATRA) reported insider share purchases by a director and 10% owner. On 11/17/2025, the reporting person bought 28,567 shares of Series A common stock in open market transactions at a weighted average price of $41.97 per share, with individual trades ranging from $41.93 to $42.00. On 11/18/2025, they bought an additional 4,631 Series A shares at a weighted average price of $41.99 per share, with trade prices ranging from $41.96 to $42.00.
After these transactions, the reporting person directly owned 484,603 shares of Series A common stock. The form also shows 10,177 shares held indirectly through the Leslie A. Malone 1995 Revocable Trust, for which the reporting person disclaims beneficial ownership. The purchases were reported on Form 4 as required for insiders of the company.